ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.66B
Market cap1.66B
Price-Earnings ratio
15.15
Price-Earnings ratio15.15
Dividend yield
—
Dividend yield—
Average volume
358.33K
Average volume358.33K
High today
$73.20
High today$73.20
Low today
$71.02
Low today$71.02
Open price
$71.08
Open price$71.08
Volume
237.16K
Volume237.16K
52 Week high
$97.00
52 Week high$97.00
52 Week low
$69.58
52 Week low$69.58

Stock Snapshot

With a market cap of 1.66B, ANI Pharmaceuticals(ANIP) trades at $72.28. The stock has a price-to-earnings ratio of 15.15.

On 2026-10-15, ANI Pharmaceuticals(ANIP) stock traded between a low of $71.02 and a high of $73.20. Shares are currently priced at $72.28, which is +1.8% above the low and -1.3% below the high.

ANI Pharmaceuticals(ANIP) shares are trading with a volume of 237.16K, against a daily average of 358.33K.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $97.00 and a 52-week low of $69.58.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $97.00 and a 52-week low of $69.58.

ANIP News

Simply Wall St 2d
ANI Pharmaceuticals Shares Moved, What Is Behind The Attention Today? - Simply Wall Street

...

ANI Pharmaceuticals Shares Moved, What Is Behind The Attention Today? - Simply Wall Street
Zacks 2d
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's ear...

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
TipRanks 3d
ANI Pharmaceuticals reports ‘positive’ results from Phase 4 Synchronicity trial

ANI Pharmaceuticals (ANIP) announced that both 6-month and 24-month data from SYNCHRONICITY, its Phase 4, open-label, single-arm clinical trial of Fluocinolone...

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.